Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Firefly Neuroscience, Inc. stock logo
AIFF
Firefly Neuroscience
$1.78
-1.1%
$1.95
$0.62
$3.77
$26.63M0.6787,073 shs436,131 shs
Definitive Healthcare Corp. stock logo
DH
Definitive Healthcare
$0.86
-3.0%
$1.06
$0.86
$4.70
$93.53M1.34278,001 shs353,949 shs
Health Catalyst, Inc. stock logo
HCAT
Health Catalyst
$1.17
-12.7%
$1.34
$0.96
$4.29
$99.02M1.63535,320 shs1.67 million shs
ROC
Rank One Computing
$6.05
$6.42
$5.15
$7.80
$115.43MN/A48,371 shs18,462 shs
5G Stocks: The Path Forward is Profitable Cover

Click the link to see MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Firefly Neuroscience, Inc. stock logo
AIFF
Firefly Neuroscience
-1.11%-6.32%+14.10%+128.21%-46.55%
Definitive Healthcare Corp. stock logo
DH
Definitive Healthcare
-2.97%-6.72%-14.85%-45.91%-74.78%
Health Catalyst, Inc. stock logo
HCAT
Health Catalyst
-12.69%-26.42%+4.46%-36.41%-72.01%
ROC
Rank One Computing
0.00%+5.95%-3.66%+604,999,900.00%+604,999,900.00%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Firefly Neuroscience, Inc. stock logo
AIFF
Firefly Neuroscience
$1.78
-1.1%
$1.95
$0.62
$3.77
$26.63M0.6787,073 shs436,131 shs
Definitive Healthcare Corp. stock logo
DH
Definitive Healthcare
$0.86
-3.0%
$1.06
$0.86
$4.70
$93.53M1.34278,001 shs353,949 shs
Health Catalyst, Inc. stock logo
HCAT
Health Catalyst
$1.17
-12.7%
$1.34
$0.96
$4.29
$99.02M1.63535,320 shs1.67 million shs
ROC
Rank One Computing
$6.05
$6.42
$5.15
$7.80
$115.43MN/A48,371 shs18,462 shs
5G Stocks: The Path Forward is Profitable Cover

Click the link to see MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Firefly Neuroscience, Inc. stock logo
AIFF
Firefly Neuroscience
-1.11%-6.32%+14.10%+128.21%-46.55%
Definitive Healthcare Corp. stock logo
DH
Definitive Healthcare
-2.97%-6.72%-14.85%-45.91%-74.78%
Health Catalyst, Inc. stock logo
HCAT
Health Catalyst
-12.69%-26.42%+4.46%-36.41%-72.01%
ROC
Rank One Computing
0.00%+5.95%-3.66%+604,999,900.00%+604,999,900.00%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Firefly Neuroscience, Inc. stock logo
AIFF
Firefly Neuroscience
1.00
SellN/AN/A
Definitive Healthcare Corp. stock logo
DH
Definitive Healthcare
2.00
Hold$2.77221.71% Upside
Health Catalyst, Inc. stock logo
HCAT
Health Catalyst
2.23
Hold$2.77136.99% Upside
ROC
Rank One Computing
3.00
Buy$9.0048.76% Upside

Current Analyst Ratings Breakdown

Latest AIFF, HCAT, ROC, and DH Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/12/2026
Health Catalyst, Inc. stock logo
HCAT
Health Catalyst
Lower Price TargetEqual Weight$2.00 ➝ $1.75
5/11/2026
Health Catalyst, Inc. stock logo
HCAT
Health Catalyst
Reiterated RatingNeutral
5/8/2026
Definitive Healthcare Corp. stock logo
DH
Definitive Healthcare
Set Price Target$1.10
5/4/2026
Firefly Neuroscience, Inc. stock logo
AIFF
Firefly Neuroscience
DowngradeSell (D-)Sell (E+)
4/28/2026
Definitive Healthcare Corp. stock logo
DH
Definitive Healthcare
UpgradeStrong SellHold
4/7/2026
ROC
Rank One Computing
Initiated CoverageBuy$9.00
3/30/2026
Definitive Healthcare Corp. stock logo
DH
Definitive Healthcare
Lower Price TargetUnderweight$2.75 ➝ $1.00
3/27/2026
Health Catalyst, Inc. stock logo
HCAT
Health Catalyst
Reiterated RatingSell (E+)
3/18/2026
Health Catalyst, Inc. stock logo
HCAT
Health Catalyst
Reiterated RatingOverweightEqual Weight$5.00 ➝ $1.00
3/13/2026
Health Catalyst, Inc. stock logo
HCAT
Health Catalyst
Lower Price TargetNeutral$4.00 ➝ $3.00
3/13/2026
Health Catalyst, Inc. stock logo
HCAT
Health Catalyst
Set Price Target$3.00
(Data available from 5/15/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Firefly Neuroscience, Inc. stock logo
AIFF
Firefly Neuroscience
$1.14M23.09N/AN/A$0.57 per share3.12
Definitive Healthcare Corp. stock logo
DH
Definitive Healthcare
$241.52M0.38$1.91 per share0.45$1.81 per share0.48
Health Catalyst, Inc. stock logo
HCAT
Health Catalyst
$311.14M0.28$1.86 per share0.63$1.87 per share0.63
ROC
Rank One Computing
$16.98M6.80N/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Firefly Neuroscience, Inc. stock logo
AIFF
Firefly Neuroscience
-$19.88M-$0.63N/AN/AN/A-565.40%-91.41%-71.04%6/30/2026 (Estimated)
Definitive Healthcare Corp. stock logo
DH
Definitive Healthcare
-$138.93M-$1.62N/A28.6777.47-76.04%4.04%1.99%N/A
Health Catalyst, Inc. stock logo
HCAT
Health Catalyst
-$177.97M-$3.72N/AN/AN/A-87.69%-3.52%-1.77%N/A
ROC
Rank One Computing
N/AN/AN/AN/AN/AN/AN/AN/AN/A

Latest AIFF, HCAT, ROC, and DH Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/14/2026Q1 2026
ROC
Rank One Computing
N/A-$0.18N/A-$0.18N/AN/A
5/12/2026Q1 2026
Firefly Neuroscience, Inc. stock logo
AIFF
Firefly Neuroscience
N/A-$0.13N/A-$0.13N/A$0.49 million
5/11/2026Q1 2026
Health Catalyst, Inc. stock logo
HCAT
Health Catalyst
$0.01$0.02+$0.01-$1.53$69.24 million$70.76 million
5/7/2026Q1 2026
Definitive Healthcare Corp. stock logo
DH
Definitive Healthcare
$0.03$0.06+$0.03-$1.32$55.02 million$55.93 million
3/31/2026Q4 2025
Firefly Neuroscience, Inc. stock logo
AIFF
Firefly Neuroscience
N/A-$0.16N/A-$0.16N/A$0.41 million
3/12/2026Q4 2025
Health Catalyst, Inc. stock logo
HCAT
Health Catalyst
$0.10$0.08-$0.02-$1.28$73.99 million$74.68 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Firefly Neuroscience, Inc. stock logo
AIFF
Firefly Neuroscience
N/AN/AN/AN/AN/A
Definitive Healthcare Corp. stock logo
DH
Definitive Healthcare
N/AN/AN/AN/AN/A
Health Catalyst, Inc. stock logo
HCAT
Health Catalyst
N/AN/AN/AN/AN/A
ROC
Rank One Computing
$1.8029.75%N/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Firefly Neuroscience, Inc. stock logo
AIFF
Firefly Neuroscience
N/A
1.43
1.39
Definitive Healthcare Corp. stock logo
DH
Definitive Healthcare
0.81
1.75
1.64
Health Catalyst, Inc. stock logo
HCAT
Health Catalyst
1.10
1.69
1.89
ROC
Rank One Computing
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
Firefly Neuroscience, Inc. stock logo
AIFF
Firefly Neuroscience
4.96%
Definitive Healthcare Corp. stock logo
DH
Definitive Healthcare
98.67%
Health Catalyst, Inc. stock logo
HCAT
Health Catalyst
85.00%
ROC
Rank One Computing
N/A

Insider Ownership

CompanyInsider Ownership
Firefly Neuroscience, Inc. stock logo
AIFF
Firefly Neuroscience
6.44%
Definitive Healthcare Corp. stock logo
DH
Definitive Healthcare
16.28%
Health Catalyst, Inc. stock logo
HCAT
Health Catalyst
2.60%
ROC
Rank One Computing
22.24%
CompanyEmployeesShares OutstandingFree FloatOptionable
Firefly Neuroscience, Inc. stock logo
AIFF
Firefly Neuroscience
N/A14.79 million13.84 millionN/A
Definitive Healthcare Corp. stock logo
DH
Definitive Healthcare
970105.52 million88.35 millionNot Optionable
Health Catalyst, Inc. stock logo
HCAT
Health Catalyst
1,20073.89 million71.97 millionOptionable
ROC
Rank One Computing
7719.08 millionN/AN/A

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Firefly Neuroscience stock logo

Firefly Neuroscience NASDAQ:AIFF

$1.78 -0.02 (-1.11%)
Closing price 05/14/2026 04:00 PM Eastern
Extended Trading
$1.80 +0.01 (+0.84%)
As of 04:30 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Firefly Neuroscience, Inc., a medical technology and artificial intelligence company, provides neuroscientific solutions that improve outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. It serves pharmaceutical companies and medical practitioners. Firefly Neuroscience, Inc. is based in Toronto, Canada.

Definitive Healthcare stock logo

Definitive Healthcare NASDAQ:DH

$0.86 -0.03 (-2.97%)
Closing price 05/14/2026 04:00 PM Eastern
Extended Trading
$0.91 +0.05 (+5.58%)
As of 04:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution. The company's platform consists of various functional areas, such as sales, marketing, clinical research and product development, strategy, talent acquisition, and physician network management. It serves biopharmaceutical and medical device companies, healthcare information technology companies, and healthcare providers; and other diversified companies comprising staffing and commercial real estate firms, financial institutions, and other organizations in the healthcare ecosystem. Definitive Healthcare Corp. was founded in 2011 and is headquartered in Framingham, Massachusetts.

Health Catalyst stock logo

Health Catalyst NASDAQ:HCAT

$1.17 -0.17 (-12.69%)
Closing price 05/14/2026 04:00 PM Eastern
Extended Trading
$1.18 +0.01 (+0.77%)
As of 05/14/2026 07:15 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases. It offers services expertise solutions comprising data and analytics, domain expertise and education, tech-enabled managed, and implementation services; and opportunity analysis and prioritization, data governance, data modeling and analysis, quality and process improvement strategy, cost accounting, data abstraction, and population health strategies. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is headquartered in South Jordan, Utah.

Rank One Computing NASDAQ:ROC

$6.05 0.00 (0.00%)
Closing price 05/14/2026 03:59 PM Eastern
Extended Trading
$6.02 -0.03 (-0.50%)
As of 05/14/2026 06:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

ROC is an independent American artificial intelligence company redefining the global standard for Vision AI in identity, security, and digital forensics. Our Vision AI platform delivers real-time facial recognition, multimodal biometric verification, video analytics, and AI-powered evidence analysis to mission-critical organizations across both private and public sectors. ROC’s biometric algorithms are routinely ranked by the National Institute of Standards and Technology (“NIST”) as among the most accurate and computationally efficient globally. Our solutions outperform legacy foreign-built systems at a fraction of the cost, with faster deployment and stronger trust. As demand for trusted AI accelerates across law enforcement, defense, and regulated commercial sectors, ROC is scaling rapidly through a growing network of integrators and multi-year deals. We are expanding from a foundation of government leadership into high-growth commercial markets such as access control, physical security, and identity verification. Our international pipeline spans the Middle East, Asia–Pacific (“APAC”), and other strategic regions where national AI and identity investments are surging. With sovereign U.S. development, deep technical leadership, a vertically integrated platform, and proven field results, we believe ROC is positioned to become the category-defining leader in operational Vision AI. ROC builds AI that sees, identifies, and interprets the physical world. Our focus is on biometric identity, digital forensics, and real-time video analytics. In a market long dominated by foreign-built legacy platforms, ROC is executing a clear mission: to restore the United States as the global leader in Vision AI. We are displacing outdated, overpriced, foreign systems with American-built solutions that are leaner, more efficient, and more affordable. We believe ROC platforms routinely cost a fraction of legacy alternatives, yet deliver higher accuracy, faster deployment, and superior customer support — all while sustaining strong margins. This operational advantage is rooted in our disciplined model: we’ve never taken outside capital, and we build everything with purpose and precision. ROC uses the term “Vision AI” as a branch of artificial intelligence focused on transforming unstructured visual data into structured, explainable insight. Vision AI is not generative or conversational. It is operational AI, built for accuracy, speed, and auditability. Whether it is deployed in a military checkpoint, a digital evidence lab, or a financial onboarding workflow, Vision AI enables real-time decisions with transparency and accountability. ROC’s algorithmic efficiency has long been a strategic advantage. Our AI models typically require only a fraction of the compute power that legacy platforms demand, allowing us to deploy faster, operate leaner, and scale without excess infrastructure. For example, an analysis published on February 20, 2024 of the National Institute of Standards and Technology (NIST) Evaluation of Latent Fingerprint Technologies (ELFT) showed that the ROC’s latent fingerprint algorithm was capable of searching a database more than 500 times faster than every other vendor who was benchmarked. Additionally, an analysis on March 8, 2023 of the NIST Face Recognition Vendor Test (FRVT) showed that the ROC face recognition algorithm ranked 61st out of 338 algorithms in hardware efficiency, while none of our key competitors ranked within the top 150 most efficient algorithms. Further, an analysis performed on February 15, 2023 of the NIST Proprietary Fingerprint Template (PFT) benchmarked that the ROC fingerprint algorithms had template comparison speeds that were the fastest of any vendor, and as much as 1000x faster than certain key competitors. This advantage has enabled us to simplify system architecture while supporting extremely large deployments through our horizontally and vertically scalable enterprise search infrastructure. ROC is routinely measured by NIST as having the most accurate and computationally efficient facial and fingerprint recognition algorithms in the world — a rare combination that enables both unmatched performance and flexible deployment. We support secure, air-gapped installations as well as cloud-native delivery, and are actively attaining Criminal Justice Information Services (“CJIS”) and related compliance standards to support our growing federal and state customer base. Our engineering team includes experts who have built mission-critical systems for the Federal Bureau of Investigation (the “FBI”) and other agencies, ensuring our platforms are secure, interoperable, and optimized for rapid integration through exposed Application Programming Interfaces (“APIs”) and robust reference applications. ROC’s mission and leadership emerged from the U.S. national security community. Prior to creating ROC, our founders, Brendan Klare and Joshua Klontz, worked within the facial recognition research group at Noblis, Inc., which is a science and technology services provider to leading U.S. national security agencies. Our founders’ work included supporting a major case study for the FBI, regarding the deployment of facial recognition technology during the course of the 2013 Boston Marathon Bombing investigation. Our CEO, B. Scott Swann, served an 18-year career with the FBI, where he fulfilled multiple executive roles, advancing technology to include Special Assistant in the FBI Director’s Office for the Science and Technology Executive Assistant Director; Executive Officer in the Office of the Director of National Intelligence; and Unit Chief at the FBI’s Criminal Justice Information Services Division. Mr. Swann led the FBI’s major case study on the Boston Marathon Bombing, through which he first met and worked with Mr. Klare and Mr. Klontz. Mr. Swann worked closely with the FBI’s CJIS division, the FBI’s central repository and search database for fingerprints and other biometric evidence. As outlined in the chart below, our growth now includes global financial companies, state and local public safety organizations, and large retail enterprises. We are rapidly expanding in access control, identity verification, and physical security applications — particularly in high-assurance and infrastructure-critical sectors. Our commercial business is scaling through an already mature channel network, and we are seeing increasing demand from global integrators who want to deliver ROC’s technology under their own brands. Our international pipeline is significant, with especially strong momentum in the Middle East and APAC regions, where governments are investing in next-generation identity and surveillance systems. These global opportunities are already driving business today and represent a substantial long-term growth vector. For the Nine months For the For the ended Year ended Year ended September December December 30, 2025 31, 2024 31, 2023 Number of customers 66 61 59 Percent of revenue for each major product -ROC SDK 32 % 43 % 33 % -ROC Watch 37 % 10 % 6 % -ROC ABIS 2 % 3 % Percent of revenue for each principal market -National Security 68 % 66 % 73 % -Fintech 17 % 22 % 15 % -Public Safety 13 % 10 % 9 % -Commercial Security and Engagement 2 % 2 % 1 % -Other 2 % Percent of revenue from the federal government and government agencies 81 % 76 % 82 % On November 19, 2019, ROC published a Code of Ethics (the “Code of Ethics”) that addressed the use of our face recognition technology. To our knowledge, ROC was the first biometric vendor to adopt such code of ethics addressing the use of face recognition technology. Subsequently, ROC has incorporated the Code of Ethics into our software licensing agreements to provide a contractual means for limiting access to our technology if a licensee violates the Code of Ethics. From the beginning, we believed that transparency, accountability, and technical rigor must go hand in hand. We build with fairness and explainability in mind and design for environments where decisions must be auditable and justifiable. That said, the broader landscape is also shifting. Adoption of face recognition and Vision AI tools is accelerating across law enforcement, defense, and critical infrastructure. Agencies that once hesitated are now embracing these capabilities — supported by clearer governance, better training, and stronger results. This growing acceptance comes at an ideal time for ROC. We are entering the public markets as demand is breaking open, not just for AI, but for trusted, operationally proven AI. ROC has been deliberately built from the ground up. Every employee has been carefully selected not just for skill but for alignment with our mission. Our team combines rising stars in artificial intelligence and Vision AI with senior engineers and practitioners who have delivered large-scale systems for the U.S. government and enterprise. We believe in talent density, small teams, and high-trust environments. Every contributor matters, and every contributor has a stake in ROC’s equity. This model has not only helped us outperform technically — it has helped us retain culture, focus, and resilience while competing against far larger and better-funded companies. Our principal executive office is located in Denver, CO.